ECSP961634A - Agonistas, antagonistas de estrogenos - Google Patents

Agonistas, antagonistas de estrogenos

Info

Publication number
ECSP961634A
ECSP961634A ECSP961634A ECSP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A
Authority
EC
Ecuador
Prior art keywords
agonists
estrogen antagonists
diseases
estrogen
antagonists
Prior art date
Application number
Other languages
English (en)
Inventor
Robert L Rosati
Kimberly O'keefe Cameron
Jardine Paul A Dasilva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961634 priority Critical patent/ECSP961634A/es
Publication of ECSP961634A publication Critical patent/ECSP961634A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de fórmula: Utiles para el tratamiento o prevención de la obesidad, cáncer de mama, osteoporosis, endometriosis, enfermedades cardiovasculares y enfermedades prostáticas.
ECSP961634 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos ECSP961634A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961634 ECSP961634A (es) 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961634 ECSP961634A (es) 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos

Publications (1)

Publication Number Publication Date
ECSP961634A true ECSP961634A (es) 1997-06-11

Family

ID=42042368

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961634 ECSP961634A (es) 1996-01-09 1996-01-09 Agonistas, antagonistas de estrogenos

Country Status (1)

Country Link
EC (1) ECSP961634A (es)

Similar Documents

Publication Publication Date Title
YU596A (sh) Estrogen agonisti/antagonisti
HU0200264D0 (en) Estrogen agonists/antagonists for the treatment of certain cancers
DK1556058T3 (da) Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
SI1187632T1 (sl) Zdravljenje z anti-ErbB2 protitelesi
EP0897726A4 (en) ANTI-CURRENT AGENT
ATE253039T1 (de) Beta 2 -adrenergische rezeptor-agonisten
EP2053129A3 (en) Method of diagnosing, monitoring, staging, imaging and treating various cancers
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
EP1129089A4 (en) SPIRO-INDOLE AS Y5 RECEPTOR ANTAGONISTS
IL149402A0 (en) Arylamine derivatives and their use as anti-telomerase agent
EA200200545A1 (ru) Онколитические комбинации для лечения рака
IS5035A (is) Aðferðir til varnar gegn brjóstakrabbameini
ZA200003236B (en) Combination therapy for the treatment of migraine.
ATE265455T1 (de) Tetrahydropyridoverbindungen
DK1079851T3 (da) Anvendelse af anti-prolactinmidler til behandling af cancer
HUP0101947A3 (en) Combination for the treatment of tumors
ECSP961634A (es) Agonistas, antagonistas de estrogenos
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
ZA200002338B (en) Combination therapy for the treatment of migraine.
WO2000036144A3 (en) Cancer diagnostic method using p40 subunit of eif3
FR2842109B1 (fr) Utilisation d'un extrait de chrysanthellum
GB2379444A9 (en) Assay for cancer of the prostate
IT1314187B1 (it) Combinazione di differenti composizioni farmaceutiche per iltrattamento del carcinoma mammario e relativo uso
ATE241991T1 (de) Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält
RU98100756A (ru) Материал для цементации меди